Targeting hypoxia-inducible factors: therapeutic opportunities and challenges.
Yuan X, Ruan W, Bobrow B, Carmeliet P, Eltzschig HK.
Nat Rev Drug Discov. 2024 Mar;23(3):175-200. doi: 10.1038/s41573-023-00848-6. Epub 2023 Dec 20.
Hypoxia challenge test and retinal circulation changes - a study using ocular coherence tomography angiography.
Sousa DC, Leal I, Moreira S, Dionísio P, Abegão Pinto L, Marques-Neves C.
Acta Ophthalmol. 2018 May;96(3):e315-e319. doi: 10.1111/aos.13622. Epub 2017 Nov 21.
The hypoxia challenge test does not accurately predict hypoxia in flight in ex-preterm neonates.
Resnick SM, Hall GL, Simmer KN, Stick SM, Sharp MJ.
Chest. 2008 May;133(5):1161-6. doi: 10.1378/chest.07-2375. Epub 2008 Jan 15.
Proteogenomic characterization of primary colorectal cancer and metastatic progression identifies proteome-based subtypes and signatures.
Tanaka A, Ogawa M, Zhou Y, Namba K, Hendrickson RC, Miele MM, Li Z, Klimstra DS, Buckley PG, Gulcher J, Wang JY, Roehrl MHA.
Cell Rep. 2024 Feb 27;43(2):113810. doi: 10.1016/j.celrep.2024.113810. Epub 2024 Feb 19.
Hypoxic Challenge Test for airflight in children with respiratory disease.
Balfour-Lynn IM.
Paediatr Respir Rev. 2017 Jan;21:62-64. doi: 10.1016/j.prrv.2016.05.002. Epub 2016 May 11.
TRPV1 mediates astrocyte activation and interleukin-1β release induced by hypoxic ischemia (HI).
Yang XL, Wang X, Shao L, Jiang GT, Min JW, Mei XY, He XH, Liu WH, Huang WX, Peng BW.
J Neuroinflammation. 2019 May 29;16(1):114. doi: 10.1186/s12974-019-1487-3.
Medical Advice for Commercial Air Travel.
Powell-Dunford N, Adams JR, Grace C.
Am Fam Physician. 2021 Oct 1;104(4):403-410.
Hypoxia Challenge Testing in Neonates for Fitness to Fly.
Vetter-Laracy S, Osona B, Peña-Zarza JA, Gil JA, Figuerola J.
Pediatrics. 2016 Mar;137(3):e20152915. doi: 10.1542/peds.2015-2915. Epub 2016 Feb 15.
Formulating Hypotheses for Different Study Designs.
Misra DP, Gasparyan AY, Zimba O, Yessirkepov M, Agarwal V, Kitas GD.
J Korean Med Sci. 2021 Dec 27;36(50):e338. doi: 10.3346/jkms.2021.36.e338.
Design strategies for chemical-stimuli-responsive programmable nanotherapeutics.
Gulfam M, Sahle FF, Lowe TL.
Drug Discov Today. 2019 Jan;24(1):129-147. doi: 10.1016/j.drudis.2018.09.019. Epub 2018 Oct 5.
